Stock Watch: Reinforcements Required As Darzalex Carries J&J
With Greater Concentration Comes Greater Responsibility For Growth
Executive Summary
Loss of exclusivity and other competitive pressures will continue to offset J&J’s pharmaceutical growth as its former blockbusters accumulate in ex-growth "other" categories. Can the pipeline take up the slack?